Director sold ~$658K of HealthEquity
Scheduled in advanceLoading…
HQY · NASDAQ · Managed Health Care
Managed Health Care company based in Draper, Utah.
In the last 90 days, no insider of HealthEquity reported an open-market purchase and 3 open-market sales worth about $1.02M. Every figure links to its official SEC, House, Senate or USAspending record.
Last closeLast close, Oct 5, 2026
$91.55
Last 12 months
Not enough history
Market value
$7.57B
Revenue
$351M
+7.6% vs the same quarter a year earlier
Free cash flow, last 12 months
$488M
This quarter $135M, a year earlier $135M
Net debt
$675M
Debt $931M, cash $256M, at Jul 31, 2026
Backlog
$3.1M
Work contracted but not yet delivered, as the company reports it
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Aug 27, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
3 sales
$1.02M sold. Insiders sell for many reasons.
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2026
$1.31B
+9.5% vs the year before
Net income, fiscal 2026
$215M
As reported in the annual filing
Shares outstanding
82.7M
As of Aug 20, 2026
In fiscal 2026 the company spent $299M buying back its own shares. Cash actually paid, from its cash-flow statement.
Director sold ~$658K of HealthEquity
Scheduled in advanceDirector sold ~$140K of HealthEquity
Scheduled in advanceOfficer sold ~$224K of HealthEquity
Scheduled in advanceOfficer sold ~$298K of HealthEquity
Scheduled in advancePrices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Last 12 months, adjusted daily closes
Adjusted close went from $87.78 on Oct 6, 2025 to $91.55 on Oct 5, 2026 (+4.3%). Disclosed activity in the last 12 months: 0 insider purchases, 13 insider sales (11 under pre-arranged plans), 0 Congress purchases, 0 Congress sales.